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Abstract
Background: Ovarian stimulation for assisted reproductive technology (ART) overcomes the
physiologic process to develop a single dominant follicle. However, following stimulation, egg
recovery rates are not 100%. The objective of this study is to determine if the follicular fluid
hormonal environment is associated with oocyte recovery.
Methods: This is a prospective study involving patients undergoing ART by standard ovarian
stimulation protocols at an urban academic medical center. A total of 143 follicular fluid aspirates
were collected from 80 patients. Concentrations of FSH, hCG, estradiol, progesterone,
testosterone and prolactin were determined. A multivariable regression analysis was used to
investigate the relationship between the follicular fluid hormones and oocyte recovery.
Results: Intrafollicular FSH was significantly associated with oocyte recovery after adjustment for
hCG (Adjusted odds ratio (AOR) = 1.21, 95%CI 1.03–1.42). The hCG concentration alone, in the
range tested, did not impact the odds of oocyte recovery (AOR = 0.99, 95%CI 0.93–1.07). Estradiol
was significantly associated with oocyte recovery (AOR = 0.98, 95% CI 0.96–0.99). After
adjustment for progesterone, the strength of association between FSH and oocyte recovery
increased (AOR = 1.84, 95%CI 1.45–2.34).
Conclusion: The relationship between FSH and oocyte recovery is significant and appears to work
through mechanisms independent of the sex hormones. FSH may be important for the physiologic
event of separation of the cumulus-oocyte complex from the follicle wall, thereby influencing
oocyte recovery. Current methods for inducing the final stages of oocyte maturation, with hCG
administration alone, may not be optimal. Modifications of treatment protocols utilizing additional
FSH may enhance oocyte recovery.
Published: 23 April 2009
Reproductive Biology and Endocrinology 2009, 7:35 doi:10.1186/1477-7827-7-35
Received: 24 November 2008
Accepted: 23 April 2009
This article is available from: http://www.rbej.com/content/7/1/35
© 2009 Rosen et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Reproductive Biology and Endocrinology 2009, 7:35 http://www.rbej.com/content/7/1/35
Page 2 of 8
(page number not for citation purposes)
Background
In order to maximize in vitro fertilization (IVF) success,
ovarian stimulation is performed to generate multiple
mature oocytes. This process overrides the physiologic
mechanisms that normally select a single dominant folli-
cle. Ovarian stimulation most typically describes the use
of exogenous gonadotropins to rescue smaller antral folli-
cles and stimulate the growth of multiple follicles simul-
taneously. This process yields numerous follicles of
varying size with variable rates of oocyte recovery [1].
The regulation of selection, growth, and ovulation of the
dominant follicle is a complex process that involves folli-
cle stimulating hormone (FSH), luteinizing hormone
(LH) and modulation by an intra-ovarian network of fac-
tors [2]. Surges in both FSH and LH precede spontaneous
ovulation, characterized by detachment of the cumulus-
oocyte complex from the follicular wall and subsequent
expulsion from the ovary [3,4]. It is well accepted that LH
is obligatory for oocyte nuclear maturation and has a fun-
damental role in ovulation. However, pure FSH has been
shown to stimulate plasminogen activator within the
granulosa cells and induce ovulation in hypophysect-
omized rats [5,6]. Plasminogen activator converts plas-
minogen to the active protease plasmin, which is
presumably involved in dissociating the oocyte from the
follicular wall and weakening the wall to facilitate rupture
[7,8].
Several studies have suggested follicular diameter corre-
lates with oocyte recovery. We hypothesize oocyte recov-
ery also has a biological basis, which is dependent upon
the follicular fluid hormonal milieu. Specifically, we
hypothesize that FSH promotes oocyte recovery by stimu-
lating follicle growth while simultaneously initiating fol-
licular hormone production. Then, FSH facilitates the
partitioning of the oocyte from the follicular wall either
directly or indirectly. Administration of human chorionic
gonadotropin (hCG) results in luteinization of the granu-
losa cells, affecting hormone production and directly or
indirectly triggering the detachment of the cumulus-
oocyte complex from the follicular wall. The aim of this
study was to determine whether any of the intrafollicular
hormones we examined would be correlated with oocyte
recovery and thereby presumably be important for the still
poorly understood process of cumulus-oocyte complex
detachment.
Methods
Study population
From April 2005 to Sept 2005, 80 patients undergoing
ART by standard ovarian stimulation protocols were
recruited to collect follicular fluid. Three stimulation pro-
tocols were utilized; down regulated (n = 62), microdose
flare (n = 10), and antagonist (n = 8). Each patient had 1
or 2 individual follicle aspirates collected at the time of
retrieval. A total of 143 follicular fluid aspirates were
obtained. One hundred and eleven follicular fluid sam-
ples were used to measure hormones. The remaining 32
samples were excluded due to blood contamination or
excessive dehydration. This study was approved by the
institutional review board at University of California, San
Francisco.
Follicular size measurement and egg retrieval
Individuals were monitored with transvaginal ultrasound
(Shimadzu SDU-450XL, Kyoto, Japan) and follicles were
measured to obtain a two-dimensional mean diameter.
HCG was administrated once two follicles measured 18
mm in mean diameter. A transvaginal ultrasound guided
follicular aspiration was conducted 36 hours post hCG
administration. Individual follicles of varying size were
randomly selected and measured before aspiration. The
follicles were categorized into 5 groups according to follic-
ular size at the time of retrieval (the mean of the two-
dimension measurements: A, ≥ 18 mm; B, 16–18 mm; C,
13–15 mm; D, 10–12 mm; E, <10 mm).
Prior to aspiration, the collection system (needle and tub-
ing) was flushed to allow for direct correlation of follicu-
lar size and fluid volume. The first follicle from either one
or both ovaries was aspirated and collected. Each follicle
was pierced with a single lumen needle and completely
aspirated. The tubing was then flushed and the contents
collected in a separate tube to ensure capture of the corre-
sponding oocyte if it was retrieved from the follicle. In
order to minimize technical differences, all egg retrievals
were performed by one of two physicians. In each patient
a maximum of two follicles were aspirated, one from each
ovary. Follicles were chosen for our study based on their
relative location within the ovary.
For each follicle, the presence or absence of an egg was
recorded immediately and the follicular fluid was placed
into a 15 ml sterile Falcon conical tube. The follicular size
was corrected to the volume of follicular fluid, with a var-
iation between the two methods of measurement averag-
ing 14.6%. The volumes corresponding to each follicle
size (<10 mm, <0.5 mL; 10–12 mm, 0.6–1 mL; 13–15
mm, 1.2–2 mL; 16–18 mm, 2.1–3 mL, and >18 mm, >3.1
mL) were similar to those previously described by Witt-
maack et al [1]. If the follicular fluid contained blood or
was notably dehydrated, the sample was excluded from
the study. The follicular fluid was cleared by centrifuga-
tion at room temperature for 10 minutes at 1500 × g, aliq-
uoted into 2 ml cryovials, and placed at -80 degrees
Celsius for later analysis.Reproductive Biology and Endocrinology 2009, 7:35 http://www.rbej.com/content/7/1/35
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Follicular fluid hormones
The following hormone concentrations were quantified in
duplicate, and measured with commercially available
automated chemiluminescent immunoassays on the
DPC-Immulite 2000 (Diagnostic Products, Los Angeles,
CA): estradiol (E2), progesterone (P), total testosterone
(T), prolactin (PRL), FSH and hCG. Prior to running sam-
ples, follicular fluid assays were validated by dilution test-
ing and confirmation of linearity. These hormones were
selected, guided by published literature, because of either
their possible or established association with follicular
development or to each other. Prior to each test the
Immulite 2000 was calibrated with 3 controls of low,
medium, and high concentrations of the appropriate hor-
mone. Dilutions were performed prior to measurement of
E2 (1:1000) and P (1:500) depending on the calibration
range. The intraassay coefficient of variations were: E2
15%, P 16%, T 13%, PRL 6.8%, and FSH 2.6%. The inte-
rassay coefficient of variations were: E2 16%, P 16%, T
16.4%, PRL 9.6%, and FSH 5.8%.
Statistical analysis
Student t-tests were performed on baseline characteristics,
and stimulation parameters to compare follicles with
oocytes recovered versus not recovered. Repeated meas-
ures ANOVA was performed to compare levels of FSH in
relation to oocyte recovery. Logistic regression analyses
were used to determine if AFC or any of the hormones
tested were associated with oocyte recovery after adjusting
for follicle size. Then, multivariate models were con-
structed to determine the independent effects of FSH and
hCG by adding one hormone at a time back to the model
to assess whether the effect of FSH on oocyte recovery was
modified. A final model was constructed adding all hor-
mones that achieved significance to determine the direct
effect of FSH on oocyte recovery. Repeated measures lin-
ear regression was used to identify the association
between follicular fluid gonadotropin and sex steroid con-
centrations. Both estrogen/progesterone and estrogen/tes-
tosterone ratios were also considered as hormone
variables. Effect modification of hormones was assessed
with an adjustment for follicle size. All analyses were per-
formed using Stata version 9.0 (Stata Corporation, Col-
lege Station, TX). Tests were declared statistically
significant for a two-sided p-value <0.05.
Results
The characteristics of patients recruited into the study and
corresponding stimulation parameters are shown in Table
1. The positive oocyte recovery group included patients
where each follicle aspirated contained an egg. If one egg
was not recovered from each aspirated follicle they were
included in the negative oocyte recovery group. Analyses
to determine whether these parameters were associated
with oocyte recovery revealed that the total antral follicle
count was inversely associated with the odds of oocyte
capture (Adjusted odds ratio (AOR) = 0.94, P = 0.016,
95%CI 0.89–0.98). The infertility diagnoses are shown in
Table 2. In comparison to an unexplained diagnosis, there
is no difference in oocyte recovery with different infertility
diagnoses. The average levels of intrafollicular FSH and
oocyte recovery separated by stimulation protocol are
depicted in Table 3.
The oocyte recovery rate was significantly associated with
follicular size. The raw results are illustrated in Figure 1.
The odds of oocyte recovery generally decreased with
decreasing size (OR: 0.63, P < 0.001, Figure 1, Figure 2).
The lead follicular group (Reference, Odds Ratio = 1) is
defined as greater than 18 mm in size. The odds of retriev-
ing an egg from follicles of 16–18 mm size was 73% (P =
0.655) compared to the lead follicular group. Oocyte
recovery from follicles that were 13–15 mm was 26% (P =
0.020) compared to the lead follicular group, and with
smaller sized follicles the chance was further decreased
(10–12 mm, 18% (P = 0.001); <10 mm, 14% (P =
0.010)). These findings are consistent with previous work
and led us to adjust the potential hormonal effects of
oocyte recovery for follicle size [1,9].
The mean follicular fluid hormone concentrations with
corresponding standard deviations according to follicular
size are summarized in Table 4. The concentrations for
FSH (P = 0.01), hCG (P = 0.006), estradiol (P = 0.03), pro-
Table 1: Patient characteristics and stimulation parameters grouped by oocyte recovery
100% oocyte recovery
N = 70
< 100% oocyte recovery
N = 41
Mean SD Mean SD OR P value CI
Age 35.53 5.96 34.81 5.17 1.07 0.221 0.95,1.20
Day 3 FSH 6.87 2.75 6.34 1.64 1.17 0.180 0.92,1.48
Start Dose 4.67 1.18 4.46 1.07 1.23 0.298 0.82,1.85
Total Dose 42.00 13.84 38.45 12.61 1.02 0.196 0.98,1.06
Antral follicle count 15.40 8.67 19.35 9.26 0.94 0.016 0.89,0.99
Stimulation days 11.07 1.14 11.14 1.19 0.98 0.939 0.65,1.48
Peak estradiol 2287.64 1252.57 2711.70 1335.41 0.94 0.264 0.95,1.02Reproductive Biology and Endocrinology 2009, 7:35 http://www.rbej.com/content/7/1/35
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gesterone (P = .0001), and prolactin (P = 0.004) were sig-
nificantly different between the follicle sizes. The
testosterone concentration did not differ (P = 0.16).
Gonadotropins (FSH, hCG) were significantly associated
with the follicular fluid hormone production. Intrafollic-
ular FSH concentration was positively associated with
estradiol concentration (P < 0.001) and progesterone con-
centration (P < 0.001) within the follicle. The FSH con-
centration did not correlate with testosterone
concentration. The hCG concentration correlated with
estrogen (P = 0.002) and progesterone concentrations (P
< 0.001), but not with the testosterone concentration.
The analyses assessing the impact of each hormone on
oocyte recovery adjusting for follicle size are shown (Table
5). Estradiol concentrations were negatively correlated
with oocyte recovery, but only slightly (AOR = 0.98, 95%
CI 0.96–0.99). The odds of oocyte recovery is 2% less for
each 10 ng/dl increase in estradiol.
The intrafollicular FSH concentration was significantly
higher when an oocyte was retrieved than when one was
not retrieved (P = 0.007, Figure 1 white versus black bars
at each follicle size). In a regression analysis, when
adjusted for follicle size, follicular FSH concentrations
showed a trend toward positive association with oocyte
recovery (AOR = 1.13, 95%CI 0.99–1.27, Table 5). This
association between follicular FSH and oocyte recovery
was strengthened and statistically significant after adjust-
ment for hCG (AOR = 1.21, 95%CI 1.03–1.42, Table 5);
i.e., the odds of retrieving an oocyte increased by 21% for
every unit (IU/L) increase of FSH in the follicular fluid
when controlled for hCG. In the range tested, hCG con-
centration alone did not impact the odds of oocyte recov-
ery (AOR = 0.99, 95%CI 0.93–1.07).
When testosterone, estradiol, progesterone, and prolactin
were each added to the FSH and hCG model, only proges-
terone influenced the impact of FSH on the rate of oocyte
recovery. It did so by strengthening the FSH and oocyte
relationship (AOR = 1.84, 95%CI 1.45–2.34). With pro-
gesterone in the model, the odds of oocyte recovery
increased by 84% for every IU/L increase in FSH. How-
ever, the independent effect of progesterone concentra-
tion was negatively associated with oocyte recovery (AOR
= 0.79, 95%CI 0.70–0.91); i.e., for every 1 ug/mL increase
in progesterone production in the presence of both FSH
and hCG, the odds of oocyte recovery decreased by 21%.
Follicular estradiol also remained an independent nega-
tive predictor of oocyte recovery in the presence of both
FSH and hCG (AOR = 0.97, 95%CI 0.95–0.99); i.e., for
every 10 ng/dl increase in estradiol, the likelihood of
oocyte recovery decreased by 3%. However, estradiol did
not modify the FSH effect on oocyte recovery. After adjust-
ing for estradiol and progesterone, while controlling for
hCG and follicle size, FSH remained an independent pre-
dictor of oocyte recovery (AOR = 1.65, 95%CI 1.22–2.20,
Table 6); i.e., the odds of oocyte recovery increased by
65% for every IU/L increase in follicular FSH.
The association of hormones and oocyte recovery previ-
ously observed was similar after adjusting for stimulation
protocol. For FSH, after adjusting for follicle size, the
effect on oocyte recovery as shown in Table 5 was AOR =
1.13 (95%CI 0.994–1.275). This is essentially the same
after also adjusting for stimulation protocol (AOR = 1.16;
95%CI 1.03–1.30). The majority of our follicle aspirates
were obtained from down regulated cycles, and even
solely within this group the association of FSH and oocyte
recovery was similar (AOR = 1.22; 95%CI 1.07–1.39).
Discussion
While the decision to go to egg retrieval is based largely
upon the size of the lead follicular group, an attempt is
usually made to retrieve oocytes regardless of follicular
size. Several studies have suggested that the chance of
recovering an oocyte decreases with smaller follicular size,
and our findings are consistent with this [1,9]. A recent
publication from our group has also shown that the odds
Table 2: Infertility diagnosis for study patients
Diagnosis Number (%)
Unexplained 37 (46)
Diminished Ovarian Reserve 12 (15)
Tubal factor 11 (14)
Ovulatory dysfunction 2 (3)
Other/Combined 18 (22)
χ2 = no difference in oocyte recovery.
Table 3: Effect of stimulation protocol on follicular FSH levels and oocyte recovery
Stimulation Protocol n Avg follicular [FSH] SD [FSH] Proportion oocyte recovery
Down Regulated 62 4.8 * 3.8 0.63
Microdose Flare 10 12.0 *ξ 3.2 0.81
Antagonist 8 7.3 ξ 3.1 0.81
* p <0.001, ξp < 0.01Reproductive Biology and Endocrinology 2009, 7:35 http://www.rbej.com/content/7/1/35
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of oocyte nuclear maturation and normal fertilization are
decreased in oocytes derived from smaller follicles [10].
Developmentally, each follicle contains an oocyte. Yet
there are reports of no oocyte recovery from IVF cycles
involving multiple mature sized follicles, and in virtually
all ovarian stimulation cycles the rate of oocyte recovery is
less than 100% relative to the number of observed folli-
cles [11]. Therefore, assuming a similar aspiration tech-
nique is used, one reason why no egg is retrieved from
certain follicles is that the cumulus-oocyte complex
remains attached to the follicular wall during aspiration.
Breaking this connection is a vital process for normal ovu-
lation, and aspirated follicles where no egg is retrieved
may allow elucidation of this process. We performed a
repeated measures logistic regression analysis examining
the oocyte recovery rates at different follicle sizes. The
results demonstrate a significant correlation with the odds
of retrieving an oocyte decreasing as the follicle size
decreases (Figure 2).
Interestingly, we found that FSH levels were higher in fol-
licles in which an oocyte was recovered, and this was sig-
nificant after adjusting for the type of ovarian stimulation
protocol. An adjustment for stimulation was made due to
different management schemes used in the protocols, as
commonly we step-down with down regulated protocols
resulting in potential differences in follicular fluid FSH
levels (Table 3). We could not adequately compare the
oocyte recovery between stimulation protocols due to
sample size. However, the fact that follicle number is
inversely predictive of oocyte recovery is consistent with
follicular fluid FSH being associated with oocyte recovery,
because down regulated cycles (which had on average
lower follicular FSH) are typically prescribed in women
with higher follicle numbers.
While FSH is an important contributor to oocyte recovery,
it is only significant after adjustment for hCG (Table 5).
This is an interesting finding, since in spontaneous ovula-
tion there is a surge in both FSH and LH. Whether the FSH
and LH surges have overlapping, complementary or
redundant functions is unknown. In high concentrations,
FSH has been shown to induce ovulation by itself in cer-
tain animal models. In hypophysectomized rats, pure
recombinant FSH as a large bolus has been shown to
induce ovulation, although the dose of FSH required was
larger than the dose of hCG needed to promote ovulation
[5,6]. In rhesus monkeys who were down regulated with
GnRH agonist and undergoing IVF, recombinant FSH was
shown to recapitulate some but not all of the characteris-
tics of recombinant hCG. Specifically, r-hFSH was equiva-
lent to r-hCG for the reinitiation of oocyte meiosis,
fertilization and granulosa cell luteinization, but a midcy-
cle FSH surge did not sustain normal luteal function [12].
A role for FSH is supported by in vitro experiments, where
both FSH and LH can promote plasminogen activator
Follicular FSH level and oocyte recovery Figure 1
Follicular FSH level and oocyte recovery. Rate of oocyte recovery and concentration FSH versus Rate of recovery (gray 
bars) and FSH concentration in cases of oocyte capture (white bars), and no oocyte capture (black bars). FSH p = 0.007 
Oocyte recovery across follicles sizes p <0.001
Figure 1Reproductive Biology and Endocrinology 2009, 7:35 http://www.rbej.com/content/7/1/35
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activity in cultured granulosa cells [6,13]. These results
also have biochemical plausibility as both FSH and LH
receptors primarily mediate downstream signaling events
through activation of the stimulatory G protein Gs with
resultant increases in intracellular cyclic AMP. Differences
in signals from G protein coupled receptors (GPCRs) that
activate the same G protein are presumably due to either
different characteristics of cyclic AMP fluxes within the
cell or the activation of alternate signaling pathways not
mediated specifically by G protein interactions [14].
Granulosa cell responsiveness to LH may be dependent
upon whether the cells have been previously exposed to
other hormones [15]. Reich et al, showed in a mouse
model that the potency of LH is enhanced in the presence
of estradiol [6]. Evidence in humans, at least in the natural
cycle, also suggests that plasminogen activity is positively
correlated with estradiol levels [16]. However, this obser-
vation was not seen in the setting of ovarian stimulation
and supraphysiologic estradiol levels, and it was suggested
that a subtle balance exists between granulosa cell secre-
tion of plasminogen activator and steroids that is dis-
turbed during controlled ovarian hyper-stimulation [16].
Although the precise functions of FSH and LH in ovula-
tion are not completely known, in ovulation induction
cycles, hCG, which activates LH receptors, is administered
to promote the periovulatory events and induce ovula-
tion. In the human menstrual cycle, there is a mid-cycle
surge in both FSH and LH secretion in the periovulatory
period. Presumably these hormones act synergistically to
promote the optimum environment for final follicle mat-
uration and ovulation. In our study, neither hCG nor FSH
alone was significantly associated with oocyte recovery
when analyzed independently. The excess amount of hCG
administered and available at the follicular level may
account for the absence of an association. Interestingly,
when both FSH and hCG were added to the model, only
FSH became an independent predictor of oocyte recovery
during follicular aspiration. Although more studies are
needed, it is possible that FSH participates in the ovula-
tion process either directly, by stimulating plasminogen
activity, or indirectly by enhancing the responsiveness to
hCG (LH) via modulation of the follicular environment
(i.e. the hormonal milieu).
The association between higher FSH concentrations
within follicles from which an oocyte was retrieved may
suggest a role for increased vascularity around these folli-
cles, since the follicular FSH is ultimately serum-derived
[12]. Following ovarian stimulation, follicles have differ-
Odds of oocyte recovery varies with follicle size Figure 2
Odds of oocyte recovery varies with follicle size. 
Adjusted odds of oocyte recovery for each follicle size com-
pared to lead follicular group (>18 mm). The relationship of 
oocyte recovery and follicle size is a monotonic trend (AOR 
= 0.63, P < 0.001)
Figure 2
Table 4: Follicular fluid hormone concentration in cases of oocyte capture (+), and no oocyte capture (-) for each follicle size
Follicle 
Size
<10 mm 10–12 mm 13–15 mm 16–18 mm >18 mm
Oocyte 
Captured
+-+-+-+-+-
(n) (2) (5) (5) (11) (12) (10) (8) (3) (43) (12)
E2 (ng/mL) 171 ± 100 289 ± 254 322 ± 266 431 ± 278 366 ± 212 442 ± 165 535 ± 308 596 ± 148 498 ± 275 484 ± 219
FSH (IU/L) 2.65 ± 3.2 1.3 ± 1.2 4.2 ± 3.2 3.45 ± 2.7 7.64 ± 3.9 
*
3.10 ± 3.1 7.80 ± 4.2 5.73 ± 2.7 6.84 ± 4.5 5.54 ± 3.9
hCG 
(IU/L)
68.5 ± 46.0 29.8 ± 27.9 105.7 ± 
55.3
85.2 ± 51.4 120.3 ± 
58.8
96.5 ± 79.2 120.9 ± 
91.8
131.0 ± 
45.1
78.9 ± 45.3 69.1 ± 21.7
P (μg/mL) 0.2 1.0 ± 0.9 2.4 ± 1.8 2.6 ± 2.1 7.2 ± 4.8 7.6 ± 6.4 12.2 ± 11.8 10.9 ± 2.8 11.8 ± 6.0 13.9 ± 3.2
PRL 
(ng/mL)
192 ± 156 100 ± 81 323 ± 118 219 ± 95 272 ± 167 369 ± 169 402 ± 289 470 ± 157 352 ± 244 443 ± 201
T (ng/dL) 655 ± 515 337 ± 219 667 ± 529 497 ± 399 385 ± 181 446 ± 148 674 ± 376 749 ± 300 585 ± 353 536 ± 165
Values represent means and standard deviations for each follicular fluid hormone.
* p <0.01Reproductive Biology and Endocrinology 2009, 7:35 http://www.rbej.com/content/7/1/35
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ent levels of oxygen tension [17]. It is possible that while
the amount of hCG is in excess, the FSH concentration
may be at a threshold and would be vulnerable to changes
in vascularity. However, if vascularity completely
explained the correlation between FSH and oocyte recov-
ery, other serum hormones impacted by changes in vascu-
larity would be expected to correlate with oocyte recovery
as well. Our data suggest there is an effect of FSH beyond
that due to vascularity alone since prolactin, which is
transported via the serum, has no association with oocyte
recovery. This implies that other mechanisms may regu-
late FSH levels within the follicle. For example, the health-
ier follicles may be secreting factors such as VEGF, which
is known to increase capillary permeability and thereby
allow for enhanced diffusion of larger molecules such as
FSH [18,19]. Another possibility is there may be seques-
tration or preferential uptake of FSH in healthier metabol-
ically active follicles.
Our analysis shows estradiol levels are inversely associ-
ated with oocyte recovery when measured alone or after
adjusting for hCG and FSH. Physiologically, follicular
estradiol is derived from androgen precursors and its pro-
duction is influenced by FSH-induced aromatase activity
[2]. In our study, while the association of FSH and estra-
diol was significant, the ratio of estradiol/testosterone was
not predictive of oocyte recovery, nor did it modify the
effect of FSH. Estradiol production normally decreases
after the midcycle surge of LH as a result of luteinization
[2]. It is possible that high concentrations of estradiol are
a surrogate marker for inadequate response of the granu-
losa cells to hCG and thus indicate decreased ability of the
oocyte to detach from the follicular wall.
A limitation of this study is that these findings are associ-
ative and cause and effect cannot be determined. Addi-
tionally, the relationship between plasma FSH and
follicular fluid FSH at the time of hCG trigger or retrieval
would be interesting to explore. Our data set is limited to
plasma FSH levels obtained when the patient is not receiv-
ing exogenous gonadotropins and therefore we cannot
explore this relationship. Another limitation is the num-
bers of patients analyzed within the subgroups of follicle
size are limited (Table 4). However, the results have bio-
logical plausibility, and provide a valid answer to the clin-
ical question of whether there are any biochemical
predictors of oocyte recovery.
The relationship between FSH and oocyte recovery was
independent of the sex steroids, but the association was
strengthened in the presence of progesterone which itself
had a negative effect on oocyte recovery (Table 6). This
suggests that oocyte recovery could be improved if we can
devise ways to increase follicular FSH without increasing
progesterone. HCG is primarily responsible for luteiniza-
tion of granulosa cells and subsequent progesterone pro-
duction. High progesterone levels in this context may be
an indicator of excess hCG or relative lack of FSH. Based
on these data, and the hypothesis that a mid-cycle bolus
of FSH will enhance oocyte recovery by promoting cumu-
lus-oocyte complex release from the follicle wall, we have
instituted a randomized, controlled study to evaluate the
Table 5: The adjusted odds of oocyte recovery for each hormone analyzed individually while adjusted for follicle size
Follicular Hormone Odds Ratio St. Error P value 95% CI
FSH (IU/L) 1.126 0.071 0.062 0.994–1.275
E2 (ng/mL) § 0.982 0.009 0.035 0.965–0.999
T (ng/dL) § 0.482 0.361 0.330 0.111–2.093
P (μg/mL) 0.946 0.043 0.224 0.864–1.035
PRL (ng/ml) 0.996 0.011 0.725 0.975–1.018
hCG (IU/L) 0.999 0.035 0.985 0.932–1.071
FSH-hCG (IU/L) †§ 1.210 0.100 0.021 1.030–1.420
† FSH adjusted for hCG
§ per 10 unit change
Table 6: Multivariate analysis: The independent effects of FSH after adjusting for hCG, progesterone, and estradiol, and controlling for 
follicle size
Follicular Hormone Odds Ratio St. Error P>|z| 95% Cl
FSH (IU/L) 1.645 0.244 0.001 1.229–2.202
hCG (IU/L) § 0.999 0.006 0.916 0.985–1.013
E2 (ng/mL) § 0.970 0.015 0.052 0.941–1.000
P (μg/mL) 0.875 0.063 0.062 0.761–1.007
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effects of FSH administration at the time of the hCG trig-
ger during IVF. More studies are needed to determine the
biological basis for the impact of FSH on oocyte recovery
and to determine whether modifying gonadotropin
administration can improve oocyte recovery rates.
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